Thoughtful vs. Dogmatic

Similar documents
IN ARTERIOVENOUS FISTULA FAILURE

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents

LUTONIX DCB in AV Access: A Single Center Experience

Regardless of whether you are a vascular surgeon,

Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience

All arteriovenous access circuits, whether native vein

ASDIN 9th Annual Scientific Meeting

Interventional Treatment for Complete Occlusion of Arteriovenous Shunt: Our Experience in 39 cases

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access

Case Endovascular management of non maturing dyalisis vascular access

Angioplasty remains the most common method

Outcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions

During the 1980s and early 1990s, the arteriovenous

The Art of Angioplasty

Hemodialysis Vascular Access Dysfunction: A Cellular and Molecular Viewpoint

Lutonix AV Clinical Trial

Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)?

Percutaneous AV Fistula Creation. Ellipsys EndoAVF System

Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB?

Disclosure Statement. Objectives. Novel Therapies for Vascular Access Dysfunction: OptiflowDevice, Gene Therapy, and Sirolimus Wrap 2/29/2012

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF

Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand

Konstantinos Katsanos, MSc, MD, PhD, EBIR

Preoperative Venous Intimal Hyperplasia, Postoperative Arteriovenous Fistula Stenosis, and Clinical Fistula Outcomes

Pathology of Cardiovascular Interventions. Body and Disease 2011

Supera for the Juxta-anastomotic AVF Stenosis

NON-MATURED ARTERIOVENOUS FISTULAE FOR HAEMODIALYSIS: DIAGNOSIS, ENDOVASCULAR AND SURGICAL TREATMENT

ENDOVASCULAR TREATMENT OF MALFUNCTIONING HAEMODIALYSIS GRAFTS/FISTULAS. Dr R Uberoi Interventional Radiologist John Radcliffe hospital Oxford.

Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care

Recurrent lesions in AV access & Initial DCB experience in India

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators

Nonsurgical Management of Postoperative Pulmonary Vein Stenosis

Lutonix AV Clinical Trial

AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose

Jimmy Wei Hwa Tan, Surg, MD

Thrombectomy, open, arteriovenous fistula without revision, autogenous or nonautogenous dialysis graft (separate procedure)

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face

First experience with DCB for treatment of dialysis access stenosis The Greek experience

Hemodialysis Fistula Maturation Consortium

III. Results and Discussion

Bare Metal Stents vs Stent Grafts

Proven Performance Through Innovative Design *

Lutonix AV Clinical Trial

Lessons & Perspectives: What is the role of Cryoplasty in SFA Intervention?

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute

Guidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter

Treating In-Stent Restenosis with Brachytherapy: Does it Actually Work?

Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program

COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access

Drug-eluting balloon for the treatment of failing hemodialytic arteriovenous fistulas

The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center

Author s Accepted Manuscript

The SplitWire Percutaneous Transluminal Angioplasty Scoring Device. Instructions for Use

A P ilots tudy inevaluationof DysfunctionalHem odialysisvascular A ccessu sings yngoiflow

Vascular Surgery and Transplant Unit University of Catania. Pierfrancesco Veroux

HD Scanning: Velocities and Volume Flow

Salvaging prosthetic dialysis fistulas with stents: Forearm versus upper arm grafts

Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley

Surgical Options in Thrombectomy for Non-Surgeons

Lutonix in AV fistula and Early look AV IDE trial data

Doppler ultrasound role in the evolution and evaluation of the complications of vascular hemodyalisis access.

Case #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty

Clinical Study Endovascular Stent Placement for Hemodialysis Arteriovenous Access Stenosis

Medical Director/Surgeon as Partners WebEx February 11, 2010

Methods of Thrombus Fragmentation & Extraction. Methods of Thrombus Extraction

2017 Cardiology Survival Guide

Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study

Disclosures. Consultant/Independent Contractor: B Braun, Teleflex, MedComp, Cook, Bard, WL Gore Royalty: Cook, Teleflex

Cephalic Arch Stenosis: A unique entity

AV ACESS COMPLICATIONS. Ass. Prof. Dr. Habas

HeRO. Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina

COVERA Vascular Covered Stents Innovation in AV Access

DCB in the treatment of av-accessa single center prospective study

BTK Intervention with Drug- Coated Balloons: Past Lessons and Future Exploration

Distal Hypoperfusion Ischemic Syndrome (DHIS)

4/30/2014. In Vitro Study of AVF Outflow Vein Wall Shear Stress and Pulse Pressure

Management of In-stent Restenosis after Lower Extremity Endovascular Procedures

PHARMACOLOGICAL TREATMENT OF ARTERIAL RESTENOSIS

Roles of Flow Mechanics in Vascular Cell Biology in Health and Disease

LUTONIX AV Clinical Trial

COVERA covered stent to treat stenosis in arteriovenous fistula: 6-month results from the prospective, multi-center, randomized AVeNEW study

Qizhuang Jin. Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China

Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward?

Role of Covered Stents and Drug Eluting Balloons In Dialysis Access

9 : , cutting balloon 9 : , PTA cutting balloon. bruit. 4 cutting balloon. WBC 5300 µl CRP 0.1 ESR. Hb 11.8 A G. X CT Fig.

*PTA Failure: Recoil >30% stenosis or more than 2 PTA s within 3 mo. Bart Dolmatch, MD

Salvageability of renal function following renal revascularization in children with Takayasu arteritis-induced renal artery stenosis

1 Description. 2 Indications. 3 Warnings ASPIRATION CATHETER

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL

RECOMMENDED INSTRUCTIONS FOR USE

Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys vascular access system

Chapter 13 Worksheet Code It

Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI

St George Hospital Renal Department Internal Policy

Ultrasound as a Tool for Preoperative Planning, Monitoring, and Interventions in Dialysis Arteriovenous Access

Case 8038 Renal allograft complicated with renal artery stenosis

Vascular. Management Of The Immature Autogenous Arteriovenous Fistula. Theodore F. Saad DOI: /

Transcription:

Debate on Balloon Assisted Maturation The Biology is Wrong: BAM Won t Work BAM Dr. Rapp Debate BIVF Dr. Lawson Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina VS. Fistula BAM vs. No BAM Failing Fistula Judgment Thoughtful vs. Dogmatic BAM No BAM 1

BAM vs. No BAM Algorithms vs. People What Debate? I will play the fool you will have me play -W. Shakespeare Success Fistulas Failure Major mode of Fistula failure Venous Stenosis Early Fistula Failure Small artery (<1.5 2mm) and small vein (<2 2.5 mm) Surgical manipulation Venipunctures Accessory veins Genetic predisposition As many as 60% of US fistulas fail to mature Late Fistula Failure Hemodynamic stress at the artery-vein anastomosis o Low shear stress o Turbulence o Compliance mismatch between artery and vein Venipunctures Angioplasty Uremia 2

Venous Stenosis smooth muscle cells Outflow Vein Proliferation Endothelial Progenitor Cells Endothelial Injury Myofibroblasts Bone marrow derived Neointimal cells Proliferation occurs from a cascade of events Mitogen-activated protein (MAP) kinase family plays a key role p42, p44 (ERK-1 and -2) ras dependent activation of p42/p44 leads to VSM proliferation Two classes of proteins can lead to MAP signaling in cells Tyrosine kinase receptors G protein coupled receptors Native Vein? Stenosis Fistula Biology Can we influence the path? Maturing Angioplasty Severe Stenosis??? Mature Occluded 3

What does Venous Angioplasty do? 1. Makes us feel better? 2. Makes the patient feel better? 3. Provides durable treatment to a diseased vessel? 4. Injures the vein it s trying to help? 5. Helps support our practice and the companies that make balloons? Endothelium Immediately Post Angioplasty Here shown is perivascular bleeding and denudation of the endothelium. 14 days later After 14 days, extensive cellular proliferation and thrombosis are apparent in the lumen. 4

The Surface of a Dysfunctional Endothelial Cell Temporal changes in CECs Following Angioplasty Angioplasty Cath only Endothelial dysfunction is characterized by the overexpression of leukocyte adhesion molecules (LAM), which serve to "capture" circulating leukocytes. These LAMs include intercellular adhesion molecule (ICAM), vascular adhesion molecule (VCAM), and the family of selectins including E- and P-selectins. Boos, C. J. et al. Chest 2007;132:1920-1926 Correlation Between CECs With sesel And vwf Among Test Subjects Increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty Investigated the activity of cellular proliferation of restenotic lesions by means of immunohistochemistry, using antibody to PCNA. Specimens from 10 primary stenotic and 20 restenotic lesions of brescia-cimino fistulae obtained during revision Chang et al Am J Kidney Dis 43 : 74 84, 2004 Boos, C. J. et al. Chest 2007;132:1920-1926 5

Human Intestine Vein at Fistula Placement Proliferation Indices in the Primary Stenotic and Restenotic Groups Primary Stenotic Vein Restenotic Vein after BAM Chang et al Am J Kidney Dis 43 : 74 84, 2004 Chang et al Am J Kidney Dis 43 : 74 84, 2004 Increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty Smooth Muscle Cell Proliferation is Proportional to the Degree of Balloon Injury Proliferation index of the restenotic group was significantly greater than that of the primary stenotic group Proliferation indices correlated negatively with the interval from PTA to restenosis and positively with the number of PTAs per lesion. Chang et al Am J Kidney Dis 43 : 74 84, 2004 Indolfi et al. Circulation. 1995;92:1230-35 6

Vascular Lesion Formation After Balloon Overstretch Injury Day 1 Day 3 Adjusted primary patency rates in surgery ( ) and percutaneous transluminal angioplasty (PTA; ) groups Day 7 Day 14 Copyright 1996 American Heart Association Scott, N. A. et al. Circulation 1996;93:2178-2187 Tessitore, N. et al. Clin J Am Soc Nephrol 2006;1:448-454 Copyright 2006 American Society of Nephrology Maintenance and Salvage of Arteriovenous Fistulas Procedures for Non-Maturing Fistulas 63 Fistulas (42%) required 209 procedures to maintain patency 3.3 procedures per fistula (1.75 procedures per access year) 174 venous angioplasty 18 arterial angioplasty 14 thrombectomy 3 ligation of side branches 2 stents Falk A, JVIR 2006 Falk A, JVIR 2006 7

Angioplasty and Venous Stenosis Still room for improvement 36-62% restenosis rate within 6 months in patients who underwent PTA Animal models of angioplasty showed SMC proliferation to be proportional to degree of vascular injury Venous smooth muscle cells (SMC) have been shown to be more sensitive to the effects of antiproliferative agents as compared to arterial SMCs. Poor integrity of internal elastic laminae of the venous wall compared with those of the arterial wall 450 ml/min Elastic Stenosis 2 minutes: 620 ml/min 3 minutes: 570 ml/min 4 minutes: 510 ml/min 5 minutes: 480 ml/min BAM!! Vessel Rupture High-grade stenosis + non-compliant balloon = vessel rupture BAM!! What does Angioplasty do? 1. Makes us feel better? 2. Makes the patient feel better? 3. Provides durable treatment to a diseased vessel? 4. Injures the vein it s trying to help? 5. Helps support our practice and the companies that make balloons? 8

Can Fistula Stenosis Be Treated? Surgical revision with patch-angioplasty or bypass Mechanical dilation of the artery and outflow vein Dilation followed by stent placement No medical (non-mechanical) therapy has been shown to treat fistula stenosis 9